KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Return on Assets (2021 - 2024)

AbCellera Biologics' Return on Assets history spans 4 years, with the latest figure at 0.03% for Q3 2024.

  • For the quarter ending Q3 2024, Return on Assets rose 5.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Sep 2024, up 5.0%, and an annual FY2024 reading of 0.11%, down 2.0% over the prior year.
  • Return on Assets for Q3 2024 was 0.03% at AbCellera Biologics, up from 0.05% in the prior quarter.
  • The five-year high for Return on Assets was 0.26% in Q1 2021, with the low at 0.1% in Q4 2023.
  • Average Return on Assets over 4 years is 0.06%, with a median of 0.1% recorded in 2022.
  • Year-over-year, Return on Assets fell -24bps in 2023 and then rose 5bps in 2024.
  • Tracing ABCL's Return on Assets over 4 years: stood at 0.12% in 2021, then dropped by -17bps to 0.1% in 2022, then tumbled by -195bps to 0.1% in 2023, then surged by 66bps to 0.03% in 2024.
  • Per Business Quant, the three most recent readings for ABCL's Return on Assets are 0.03% (Q3 2024), 0.05% (Q2 2024), and 0.07% (Q1 2024).